MedTrace Logo

Radiofrequency-assisted Liver Resection in Intractable Liver Cancer

NCT04413526 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 199

Last updated 2021-11-19

No results posted yet for this study

Summary

In this retrospective study, the investigators assessed the application of radiofrequency-assisted liver resection in intractable liver cancer resection, and plan to analysis the different factors.

Conditions

Interventions

PROCEDURE

radiofrequency

radiofrequency combined with liver resection

PROCEDURE

TACE

only TACE treatment

PROCEDURE

TACE+radiofrequency

TACE followed by radiofrequency

Sponsors & Collaborators

  • Hepatopancreatobiliary Surgery Institute of Gansu Province

    lead OTHER

Principal Investigators

  • Wenbo Meng, M.D., Ph. D. · Hepatopancreatobiliary Surgery Institute of Gansu Province

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-25
Primary Completion
2021-11-18
Completion
2021-11-18

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04413526 on ClinicalTrials.gov